Ram Chandra Panthi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ram Chandra Panthi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Sanjeev Gautam
Department of Internal Medicine Karnali Academy of Health Sciences Jumla Nepal
3 shared publications - Sudeep Adhikari
Oxford University Clinical Research Unit Nepal, Lalitpur, Nepal
3 shared publications Bimal Pandey
Internal Medicine, Patan Academy of Health Sciences, Lalitpur, Nepal
2 shared publications- Buddha Basnyat
Lalitpur Bagmati 44700 Oxford University Clinical Research Unit
2 shared publications Janak Koirala
Internal Medicine, Patan Academy of Health Sciences, Lalitpur, Nepal
2 shared publications- Manish Rokaya
MPH student, School of Public Health, KAHS, Jumla Nepal
2 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by Karnali Academy of Health Sciences in Journal of Karnali Academy of Health Sciences
- Vol. 9 (2) , 94-96
Quality improvement audit on cardiovascular disease risk management in patients with type II diabetes mellitus
Introduction: The American Diabetes Association standards of care 2021 recommend statins for all patients with diabetes mellitus aged 40 to 75 years. This quality improvement audit was done to improve adherence to these guidelines in the Internal Medicine outpatient clinic of Patan Academy of Health Sciences, Nepal. Methods: This study was conducted according to the Plan-Do-Study-Act (PDSA) cycle. All patients aged 40 to 75 years with type 2 diabetes mellitus were included. Pregnant patients were excluded from study. A baseline study was conducted in the outpatient internal medicine clinic of Patan Academy of Health Sciences, Nepal, from 2021 October 18 to 2021 October 25, on all eligible patients. Based on the results, objectives were set to ensure that 90% of patients in the OPD with diabetes mellitus receive statin when indicated and that at least 50% of patients with diabetes mellitus receive the dose per ASCVD risk. The intervention was through pamphlets, department presentations, and formal and informal feedback. A post-intervention follow-up study was conducted from 4th September to 9th September 2022, at the same site. Results: Patients who were taking statins increased from 46% (N=54) to 95% (N=41). Patients who were taking appropriate doses of statins increased from 24% (N=54) to 80% s(N=41). Conclusions: Considering the potential benefits and the project’s initial success, we recommend continuing the project and considering it in other centers as well.
- 10 September 2026
- Published by Karnali Academy of Health Sciences in Journal of Karnali Academy of Health Sciences
- Vol. 9 (2) , 94-96
Open AccessQuality improvement audit on cardiovascular disease risk management in patients with type II diabetes mellitus
Introduction: The American Diabetes Association standards of care 2021 recommend statins for all patients with diabetes mellitus aged 40 to 75 years. This quality improvement audit was done to improve adherence to these guidelines in the Internal Medicine outpatient clinic of Patan Academy of Health Sciences, Nepal. Methods: This study was conducted according to the Plan-Do-Study-Act (PDSA) cycle. All patients aged 40 to 75 years with type 2 diabetes mellitus were included. Pregnant patients were excluded from study. A baseline study was conducted in the outpatient internal medicine clinic of Patan Academy of Health Sciences, Nepal, from 2021 October 18 to 2021 October 25, on all eligible patients. Based on the results, objectives were set to ensure that 90% of patients in the OPD with diabetes mellitus receive statin when indicated and that at least 50% of patients with diabetes mellitus receive the dose per ASCVD risk. The intervention was through pamphlets, department presentations, and formal and informal feedback. A post-intervention follow-up study was conducted from 4th September to 9th September 2022, at the same site. Results: Patients who were taking statins increased from 46% (N=54) to 95% (N=41). Patients who were taking appropriate doses of statins increased from 24% (N=54) to 80% s(N=41). Conclusions: Considering the potential benefits and the project’s initial success, we recommend continuing the project and considering it in other centers as well.
- Open Access
- 1 April 2026
- Published by Karnali Academy of Health Sciences in Journal of Karnali Academy of Health Sciences
Assessment of physical activity level in diabetes mellitus patients: A cross-sectional study at the tertiary hospital
Introduction: Diabetes mellitus is a major public health concern globally and in Nepal, with a rising burden in rural and underserved regions such as Karnali Province. Physical activity is a key component of diabetes management, yet data from rural Nepal are limited. This study assessed physical activity levels among patients with diabetes mellitus attending a tertiary center and examined their association with glycemic control indicators. Methods: This was a cross-sectional study conducted in a tertiary care center of Nepal, among patients aged ≥20 years with diagnosed diabetes mellitus who attended the hospital during the study period of April 2025 to October 2025. Physical activity was assessed using a structured questionnaire adapted from the International Physical Activity Questionnaire. Glycemic control indicators (HbA1c, fasting blood glucose, and 2-hour postprandial blood glucose) were obtained from laboratory records. Following data collection, statistical analysis was conducted using SPSS 22 software. Descriptive statistics and chisquare tests were applied. Results: Among all participants (N = 145), about two-thirds (66.21%) had poor glycemic control, i.e., HbA1c≥ 6.5%. Nearly 67% reported engaging in more than 600 MET-minutes per week of moderate physical activity, meeting the WHO-recommended levels. Higher physical activity was significantly associated with lower fasting plasma glucose and with lower postprandial blood glucose, although the latter association was not statistically significant. Conclusion: Inadequate glycemic control remained common among diabetes patients and correlated poorly with glycemic control. Integrating physical activity promotion with routine clinical care and public health interventions is essential. Keywords: Cross-sectional study, Diabetes mellitus, Glycemic control, Nepal, Physical activity
- 1 April 2026
- Published by Karnali Academy of Health Sciences in Journal of Karnali Academy of Health Sciences
Open AccessAssessment of physical activity level in diabetes mellitus patients: A cross-sectional study at the tertiary hospital
Introduction: Diabetes mellitus is a major public health concern globally and in Nepal, with a rising burden in rural and underserved regions such as Karnali Province. Physical activity is a key component of diabetes management, yet data from rural Nepal are limited. This study assessed physical activity levels among patients with diabetes mellitus attending a tertiary center and examined their association with glycemic control indicators. Methods: This was a cross-sectional study conducted in a tertiary care center of Nepal, among patients aged ≥20 years with diagnosed diabetes mellitus who attended the hospital during the study period of April 2025 to October 2025. Physical activity was assessed using a structured questionnaire adapted from the International Physical Activity Questionnaire. Glycemic control indicators (HbA1c, fasting blood glucose, and 2-hour postprandial blood glucose) were obtained from laboratory records. Following data collection, statistical analysis was conducted using SPSS 22 software. Descriptive statistics and chisquare tests were applied. Results: Among all participants (N = 145), about two-thirds (66.21%) had poor glycemic control, i.e., HbA1c≥ 6.5%. Nearly 67% reported engaging in more than 600 MET-minutes per week of moderate physical activity, meeting the WHO-recommended levels. Higher physical activity was significantly associated with lower fasting plasma glucose and with lower postprandial blood glucose, although the latter association was not statistically significant. Conclusion: Inadequate glycemic control remained common among diabetes patients and correlated poorly with glycemic control. Integrating physical activity promotion with routine clinical care and public health interventions is essential. Keywords: Cross-sectional study, Diabetes mellitus, Glycemic control, Nepal, Physical activity
- 31 December 2024
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 4 (2) , 128-132
Status of Vitamin D among Patients Attending Internal Medicine Department in a Tertiary Care Centre of Rural Nepal: A Hospital Based Cross-Sectional Study
Background: Vitamin D deficiency is a pandemic with global prevalence estimated to be 47.9%. Many factors like sunlight exposure, seasonal and geographic variability affect vitamin D levels. This study, conducted in a high altitude location of the mountainous region of western Nepal helps to identify prevalence and associated factors of vitamin D deficiency. Methods: This was a hospital based observational, cross sectional study done on 372 patients attending internal medicine outpatient department of Karnali Academy of Health Sciences, Jumla during June to September 2025. Serum vitamin D levels were assessed and the distribution of vitamin D levels with age, sex, ethnicity, occupation and education studied. Vitamin D levels were characterised as 5(OH)D concentration 50nmol/L or 20ng/ml as vitamin D deficiency, serum 25(OH)D levels of 51-74 nmol/L or 21-29ng/ml as insufficiency, and levels ≥30 ng/ml as sufficient. Results: Prevalence of vitamin D deficiency was 34% and insufficiency was 43%. The prevalence of vitamin D deficiency was significantly higher among females (38%, compared to 26% in males), those with indoor activity (53%) and those with university education (53%). There was no difference in vitamin D levels between age or ethnicity.Conclusion: Overall 77% had inadequate vitamin D levels. Most affected groups were female, those with indoor activity and those with university education.
- 31 December 2024
- Published by Nepal Journals Online (JOL) in Journal of National Heart and Lung Society Nepal
- Vol. 4 (2) , 128-132
Status of Vitamin D among Patients Attending Internal Medicine Department in a Tertiary Care Centre of Rural Nepal: A Hospital Based Cross-Sectional Study
Background: Vitamin D deficiency is a pandemic with global prevalence estimated to be 47.9%. Many factors like sunlight exposure, seasonal and geographic variability affect vitamin D levels. This study, conducted in a high altitude location of the mountainous region of western Nepal helps to identify prevalence and associated factors of vitamin D deficiency. Methods: This was a hospital based observational, cross sectional study done on 372 patients attending internal medicine outpatient department of Karnali Academy of Health Sciences, Jumla during June to September 2025. Serum vitamin D levels were assessed and the distribution of vitamin D levels with age, sex, ethnicity, occupation and education studied. Vitamin D levels were characterised as 5(OH)D concentration 50nmol/L or 20ng/ml as vitamin D deficiency, serum 25(OH)D levels of 51-74 nmol/L or 21-29ng/ml as insufficiency, and levels ≥30 ng/ml as sufficient. Results: Prevalence of vitamin D deficiency was 34% and insufficiency was 43%. The prevalence of vitamin D deficiency was significantly higher among females (38%, compared to 26% in males), those with indoor activity (53%) and those with university education (53%). There was no difference in vitamin D levels between age or ethnicity.Conclusion: Overall 77% had inadequate vitamin D levels. Most affected groups were female, those with indoor activity and those with university education.
- Open Access
- 21 March 2024
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 8, 226
Case Report: Intrahepatic cholestasis: a diagnostic dilemma
Cholestasis is an impairment of bile formation or bile flow. The mechanisms of cholestasis can be broadly classified into intrahepatic and extrahepatic. Most of the time, etiology can be determined with proper history, physical examination, and diagnostic testing including laboratory and imaging tests. This is a case report of a patient with severe cholestasis who underwent extensive evaluation to determine the etiology of intrahepatic cholestasis. This Case Report details a 28-year-old male who presented with seven days’ history of yellowish discoloration of eyes, the passage of dark-colored urine, generalized body itching, and the passage of clay-colored stool. The patient had no similar episode in the past. Laboratory investigations showed unconjugated hyperbilirubinemia and increased alkaline phosphatase. Magnetic resonance cholangiopancreaticography was unremarkable and liver biopsy was suggestive of cholestatic pattern and negative for acute hepatitis. The bilirubin level started decreasing after a month. The etiology of intrahepatic cholestasis remained unknown. Genotyping could not be done due to limited available resources. It may have helped to diagnose familial hepatocellular cholestasis such as benign recurrent intrahepatic cholestasis (BRIC) and progressive familial intrahepatic cholestasis. Gamma-glutamyl transferase is normal or mildly elevated in patients with BRIC. A similar picture was seen in our case as well. If the patient presents again with similar symptoms and findings, we can consider the diagnosis of BRIC.
- 21 March 2024
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 8, 226
Open AccessCase Report: Intrahepatic cholestasis: a diagnostic dilemma
Cholestasis is an impairment of bile formation or bile flow. The mechanisms of cholestasis can be broadly classified into intrahepatic and extrahepatic. Most of the time, etiology can be determined with proper history, physical examination, and diagnostic testing including laboratory and imaging tests. This is a case report of a patient with severe cholestasis who underwent extensive evaluation to determine the etiology of intrahepatic cholestasis. This Case Report details a 28-year-old male who presented with seven days’ history of yellowish discoloration of eyes, the passage of dark-colored urine, generalized body itching, and the passage of clay-colored stool. The patient had no similar episode in the past. Laboratory investigations showed unconjugated hyperbilirubinemia and increased alkaline phosphatase. Magnetic resonance cholangiopancreaticography was unremarkable and liver biopsy was suggestive of cholestatic pattern and negative for acute hepatitis. The bilirubin level started decreasing after a month. The etiology of intrahepatic cholestasis remained unknown. Genotyping could not be done due to limited available resources. It may have helped to diagnose familial hepatocellular cholestasis such as benign recurrent intrahepatic cholestasis (BRIC) and progressive familial intrahepatic cholestasis. Gamma-glutamyl transferase is normal or mildly elevated in patients with BRIC. A similar picture was seen in our case as well. If the patient presents again with similar symptoms and findings, we can consider the diagnosis of BRIC.
- Open Access
- 24 May 2023
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 8, 226
Case Report: Intrahepatic cholestasis: a diagnostic dilemma
Cholestasis is an impairment of bile formation or bile flow. The mechanisms of cholestasis can be broadly classified into intrahepatic and extrahepatic. Most of the time, etiology can be determined with proper history, physical examination and diagnostic testing including laboratory and imaging tests. This is a case report of a patient with severe cholestasis who underwent extensive evaluation to determine the etiology of intrahepatic cholestasis. This Case Report details a 28-year-old male who presented with seven days’ history of yellowish discoloration of eyes, passage of dark colored urine, generalized body itching, and passage of clay colored stool. Patient had no similar episode in the past. Laboratory investigations showed unconjugated hyperbilirubinemia and increased alkaline phosphatase. Magnetic resonance cholangiopancreaticography was unremarkable and liver biopsy was suggestive of cholestatic pattern and negative for acute hepatitis. The bilirubin level started decreasing after a month. The etiology of intrahepatic cholestasis remained unknown. Genotyping could not be done due to limited available resources. It may have helped to diagnose familial hepatocellular cholestasis such as benign recurrent intrahepatic cholestasis (BRIC) and progressive familial intrahepatic cholestasis. Gamma glutamyl transferase is normal or mildly elevated in patients with BRIC. A similar picture was seen in our case as well. If the patient presents again with similar symptoms and findings, we can consider the diagnosis of BRIC.
- 24 May 2023
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 8, 226
Open AccessCase Report: Intrahepatic cholestasis: a diagnostic dilemma
Cholestasis is an impairment of bile formation or bile flow. The mechanisms of cholestasis can be broadly classified into intrahepatic and extrahepatic. Most of the time, etiology can be determined with proper history, physical examination and diagnostic testing including laboratory and imaging tests. This is a case report of a patient with severe cholestasis who underwent extensive evaluation to determine the etiology of intrahepatic cholestasis. This Case Report details a 28-year-old male who presented with seven days’ history of yellowish discoloration of eyes, passage of dark colored urine, generalized body itching, and passage of clay colored stool. Patient had no similar episode in the past. Laboratory investigations showed unconjugated hyperbilirubinemia and increased alkaline phosphatase. Magnetic resonance cholangiopancreaticography was unremarkable and liver biopsy was suggestive of cholestatic pattern and negative for acute hepatitis. The bilirubin level started decreasing after a month. The etiology of intrahepatic cholestasis remained unknown. Genotyping could not be done due to limited available resources. It may have helped to diagnose familial hepatocellular cholestasis such as benign recurrent intrahepatic cholestasis (BRIC) and progressive familial intrahepatic cholestasis. Gamma glutamyl transferase is normal or mildly elevated in patients with BRIC. A similar picture was seen in our case as well. If the patient presents again with similar symptoms and findings, we can consider the diagnosis of BRIC.
- Open Access
- 16 June 2022
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 7, 171
Case Report: Paraquat poisoning
Paraquat (1, 1′-dimethyl-4,4′-bipyridinium) is a commonly used herbicide that is highly toxic when ingested. Ingestion of toxic doses of paraquat has serious complications on the lungs, gastrointestinal tract, kidney, liver, and other organs. Due to its inherent toxicity and the lack of a specific antidote, it has a high case fatality rate. Despite being restricted to commercially licensed users in Nepal, it is a common herbicide causing both intentional and accidental poisoning. Although there have been numerous anecdotal cases of paraquat poisoning in Nepal, no reports have been published in the literature. . We report a case of a 30-year old female, who developed gastrointestinal symptoms like vomiting, diarrhoea and odynophagia, renal and liver injury after accidental ingestion of 10ml of 20% paraquat. Symptoms and organ involvement subsided with timely and appropriate supportive management.
- 16 June 2022
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 7, 171
Open AccessCase Report: Paraquat poisoning
Paraquat (1, 1′-dimethyl-4,4′-bipyridinium) is a commonly used herbicide that is highly toxic when ingested. Ingestion of toxic doses of paraquat has serious complications on the lungs, gastrointestinal tract, kidney, liver, and other organs. Due to its inherent toxicity and the lack of a specific antidote, it has a high case fatality rate. Despite being restricted to commercially licensed users in Nepal, it is a common herbicide causing both intentional and accidental poisoning. Although there have been numerous anecdotal cases of paraquat poisoning in Nepal, no reports have been published in the literature. . We report a case of a 30-year old female, who developed gastrointestinal symptoms like vomiting, diarrhoea and odynophagia, renal and liver injury after accidental ingestion of 10ml of 20% paraquat. Symptoms and organ involvement subsided with timely and appropriate supportive management.